RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

Folks can chime in an correct, but my take is their new formulations for dronabinol OSA trials are undergoing preclincal evaluations. Once these are complete, they hope to bypass some of the clinicals and move into phase 3 human trials, since dronabinol has been tested much in the past in clinical trials. Not sure where they are at on moving forward with this since there has been zero update along these lines. I kinda feel it makes sense to figure out what they are doing with NIH and possible BP involvement there before moving forward too much with the other programs, since funding capacity will be dictated by such.

It does seem awfully quiet with no effort on 10-k and no recent communications all things considered.

good luck to us all...